Hypoxic conditions increases H2S-induced ER stress in A2870 cells
- 308 Downloads
Hypoxia—a state of lower oxygen demand—is responsible for a higher aggressiveness of tumors and therefore a worse prognosis. During hypoxia, several metabolic pathways are re-organized, e.g., energetic metabolism, modulation of pH, and calcium transport. Calcium is an important second messenger that regulates variety of processes in the cell. Thus, aim of this work was to compare H2S modulation of the intracellular calcium transport systems in hypoxia and in cells grown in standard culture conditions. For all experiments, we used ovarian cancer cell line (A2780). H2S is a novel gasotransmitter, known to be involved in a modulation of several calcium transport systems, thus resulting in altered calcium signaling. Two models of hypoxia were used in our study—chemical (induced by dimethyloxallyl glycine) and 2 % O2 hypoxia, both combined with a treatment using a slow H2S donor GYY4137. In hypoxia, we observed rapid changes in cytosolic and reticular calcium levels compared to cells grown in standard culture conditions, and these changes were even more exagerrated when combined with the GYY4137. Changes in a calcium homeostasis result from IP3 receptor´s up-regulation and down-regulation of the SERCA 2, which leads to a development of the endoplasmic reticulum stress. Based on our results, we propose a higher vulnerability of calcium transport systems to H2S regulation under hypoxia.
KeywordsH2S Hypoxia Intracellular calcium IP3 receptors Cancer Apoptosis
This work was supported by grants APVV-14-0351, APVV-0045-11, and VEGA 2/0082/16.
Compliance with ethical standards
Conflict of interest
The authors declare that there are no conflicts of interest.
- 5.Pacifico F, Ulianich L, De Micheli S, Treglia S, Leonardi A, Vito P, Formisano S, Consiglio E, Di Jeso B (2003) The expression of the sarco/endoplasmic reticulum Ca2+-ATPases in thyroid and its down-regulation following neoplastic transformation. J Mol Endocrinol 30:399–409CrossRefPubMedGoogle Scholar
- 6.Ghosh S, Adhikary A, Chakraborty S, Nandi P, Mohanty S, Chakraborty S, Bhattacharjee P, Mukherjee S, Putatunda S, Chakraborty S, Chakraborty A, Sa G, Das T, Sen PC (2012) Nifetepimine, a dihydropyrimidone, ensures CD4 T cell survival in a tumor microenvironment by Maneuvering Sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA). J Biol Chem 287:32881–32896CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Zhong F, Harr MW, Bultynck G, Monaco G, Parys JB, De Smedt H, Rong YP, Molitoris JK, Lam M, Ryder Ch, Matsuyama S, Distelhorst CW (2011) Induction of Ca2-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2–IP3 receptor interaction. Blood 117:2924–2934CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Hedgepeth SC, Garcia MI, Wagner LE II, Rodriguez AM, Chintapalli SV, Snyder RR, Hankins GDV, Henderson BR, Brodie KM, Yule DI, van Rossum DB, Boehning D (2015) The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release. J Biol Chem. doi: 10.1074/jbc.M114.611186 PubMedGoogle Scholar
- 18.Jurkovicova D, Sedlakova B, Lacinova L, Kopacek J, Sulova Z, Sedlak J, Krizanova O (2008) Hypoxia differently modulates gene expression of inositol 1,4,5-trisphosphate receptors in mouse kidney and HEK 293 cell line. Ann N Y Acad Sci 1148:421–427. doi: 10.1196/annals.1410.034 CrossRefPubMedGoogle Scholar
- 23.Jakubikova J, Cervi D, Ooi M, Kim K, Nahar S, Klippel S, Cholujova D, Leiba M, Daley JF, Delmore J, Negri J, Blotta S, McMillin DW, Hideshima T, Richardson PG, Sedlak J, Anderson KC, Mitsiades CS (2011) Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica 96:1170–1179. doi: 10.3324/haematol.2010.029363 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Pastorek M, Simko V, Takacova M, Barathova M, Bartosova M, Hunakova L, Sedlakova O, Hudecova S, Krizanova O, Dequiedt F, Pastorekova S, Sedlak J (2015) Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy. Int J Oncol. doi: 10.3892/ijo.2015.2987 PubMedPubMedCentralGoogle Scholar